# Red Cell Distribution Width and Lactate Albumin Ratio as Prognostic Markers for Mortality in Sepsis and Septic Shock

> **NCT05921825** · — · UNKNOWN · sponsor: **Tanta University** · enrollment: 70 (estimated)

## Conditions studied

- Morality
- Sepsis
- Septic Shock

## Interventions

- **DIAGNOSTIC_TEST:** Red cell distribution width
- **DIAGNOSTIC_TEST:** lactate albumin ratio measurement

## Key facts

- **NCT ID:** NCT05921825
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-01
- **Primary completion:** 2024-01-30
- **Final completion:** 2024-01-30
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2023-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05921825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05921825, "Red Cell Distribution Width and Lactate Albumin Ratio as Prognostic Markers for Mortality in Sepsis and Septic Shock". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05921825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*